Bone marrow endothelial cells express the osteoclastogenic factor RANKL and its decoy receptor OPG: Evidence for a role in the development of myeloma bone disease.

समान संसाधन

• Bone marrow endothelial cells produce osteoprotegerin: Evidence for a role in the development of myeloma bone disease
  द्वारा: De Leenheer, E, और अन्य
  प्रकाशित: (2004)
• Tumour cells isolated from patients with multiple myeloma express the critical osteoclastogenic factor, RANKL.
  द्वारा: Shipman, C, और अन्य
  प्रकाशित: (2000)
• Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?
  द्वारा: Shipman, C, और अन्य
  प्रकाशित: (2002)
• Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
  द्वारा: Croucher, P, और अन्य
  प्रकाशित: (2003)
• Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
  द्वारा: Croucher, P, और अन्य
  प्रकाशित: (2000)